TRESCON
|
TRESCON Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.40 | 0.18 | 0.27 | 0.50 | 0.01 |
| CEPS(Rs) | 0.40 | 0.18 | 0.30 | 0.58 | 0.01 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 15.16 | 14.76 | 14.58 | 14.34 | 13.83 |
| Tax Rate(%) | 15.98 | 22.86 | 42.51 | 14.54 | 80.75 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | - | -64.56 | -18.13 | - | -2.68 |
| EBIT Margin(%) | - | 137.91 | 101.61 | - | 3.41 |
| Pre Tax Margin(%) | - | 137.25 | 93.43 | - | 1.35 |
| PAT Margin (%) | - | 105.88 | 53.72 | - | 0.26 |
| Cash Profit Margin (%) | - | 107.01 | 59.87 | - | 0.28 |
| Performance Ratios | |||||
| ROA(%) | 2.62 | 1.19 | 1.84 | 3.25 | 0.10 |
| ROE(%) | 2.66 | 1.22 | 1.98 | 3.68 | 0.13 |
| ROCE(%) | 3.15 | 1.58 | 3.59 | 4.38 | 1.44 |
| Asset Turnover(x) | - | 0.01 | 0.03 | - | 0.39 |
| Sales/Fixed Asset(x) | - | 1.03 | 2.36 | - | 31.92 |
| Working Capital/Sales(x) | - | 0.02 | 0.07 | - | 0.83 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | 0.97 | 0.42 | 357.23 | 0.03 |
| Receivable days | - | 666.46 | 214.51 | - | 46.73 |
| Inventory Days | - | - | - | - | - |
| Payable days | - | 300.50 | 105.74 | - | 54.81 |
| Valuation Parameters | |||||
| PER(x) | 20.83 | 101.04 | 211.94 | 122.92 | 9,051.28 |
| PCE(x) | 20.79 | 99.97 | 190.18 | 107.15 | 8,252.95 |
| Price/Book(x) | 0.55 | 1.23 | 3.96 | 4.32 | 6.74 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | - | 106.06 | 113.38 | - | 23.35 |
| EV/Core EBITDA(x) | 17.38 | 76.28 | 97.01 | 84.00 | 680.68 |
| EV/EBIT(x) | 17.67 | 76.90 | 111.58 | 93.36 | 685.70 |
| EV/CE(x) | 0.54 | 1.20 | 3.78 | 3.89 | 5.84 |
| M Cap / Sales | - | 106.98 | 113.85 | - | 23.50 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -100.00 | -66.65 | - | -99.98 | 5.92 |
| Core EBITDA Growth(%) | 104.70 | -60.32 | -11.01 | 475.49 | -48.48 |
| EBIT Growth(%) | 102.99 | -54.73 | -14.01 | 421.60 | -48.77 |
| PAT Growth(%) | 122.09 | -34.26 | -39.95 | 5,080.85 | -89.18 |
| EPS Growth(%) | 122.12 | -34.26 | -45.89 | 4,788.18 | -97.97 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | 0.01 | 0.01 | 0.06 | 0.09 |
| Current Ratio(x) | 65.40 | 75.92 | 14.09 | 4.61 | 4.35 |
| Quick Ratio(x) | 65.40 | 75.92 | 14.09 | 4.61 | 4.35 |
| Interest Cover(x) | 4,788.57 | 209.03 | 12.43 | 8.76 | 1.66 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | - | 0.01 | 0.02 |
Compare Financial Ratios of peers of TRESCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRESCON | ₹115.1 Cr | 0.1% | 10.2% | 25.7% | Stock Analytics | |
| INDRAYANI BIOTECH | ₹259.4 Cr | -2.1% | 5.7% | -33.7% | Stock Analytics | |
TRESCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRESCON | 0.1% |
10.2% |
25.7% |
| SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses
